# Clustering Approach 4 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.020928444595848	Range of duration = 0.03 to 223.96, nDeath = 60, nCensor = 130
2	AGE	ANOVA	0.286841630845833	Range of values = 40 to 86, Mean = 65.2895, StdDev = 9.86981, nMissing = 28
3	GENDER	Fisher's exact test	0.0240176400855334	nTypes = 2 (FEMALE/MALE), nPatients = 116/102
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.678735091106815	Range of values = 0 to 100, Mean = 71.1111, StdDev = 34.2807, nMissing = 200
5	HISTOLOGICAL.TYPE	Chi-square test	0.274163870772661	nTypes = 11 (LUNG ACINAR ADENOCARCINOMA/LUNG ADENOCARCINOMA MIXED SUBTYPE/LUNG ADENOCARCINOMA- NOT OTHERWISE SPECIFIED (NOS)/LUNG BRONCHIOLOALVEOLAR CARCINOMA MUCINOUS/LUNG BRONCHIOLOALVEOLAR CARCINOMA NONMUCINOUS/LUNG CLEAR CELL ADENOCARCINOMA/LUNG MICROPAPILLARY ADENOCARCINOMA/LUNG MUCINOUS ADENOCARCINOMA/LUNG PAPILLARY ADENOCARCINOMA/LUNG SOLID PATTERN PREDOMINANT ADENOCARCINOMA/MUCINOUS (COLLOID) ADENOCARCINOMA), nPatients = 5/49/133/3/10/1/2/2/9/1/3
6	PATHOLOGY.T	Chi-square test	0.84021593492648	nTypes = 4 (T1/T2/T3/T4), nPatients = 60/126/17/13, nMissing = 2
7	PATHOLOGY.N	Chi-square test	0.400011354208007	nTypes = 3 (N0/N1/N2+N3), nPatients = 127/44/42, nMissing = 5
8	PATHOLOGICSPREAD(M)	Chi-square test	0.257624026820953	nTypes = 3 (M0/M1/MX), nPatients = 140/10/62, nMissing = 6
9	TUMOR.STAGE	Chi-square test	0.695296795164886	nTypes = 4 (I/II/III/IV), nPatients = 108/47/47/11, nMissing = 5
10	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.0788446711927438	nTypes = 2 (NO/YES), nPatients = 15/203
11	NEOADJUVANT.THERAPY	Fisher's exact test	0.358593456921609	nTypes = 2 (NO/YES), nPatients = 32/186